Skip to main content

Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

The Original Article was published on 06 December 2017

Correction to: Breast Cancer Research 19, 130 (2017)

http://dx.doi.org/10.1186/s13058-017-0920-8

Following publication of the original article [1], the authors would like to correct several typos in the article text:

  1. 1)

    Page 4-right panel, Line 10: “The take rate was 51.3% (21/39; 95% CI: 34.8-67.6%) in TN subtype;”. Take rate should be 20/39 not 21/39. Percentages are correct.

  2. 2)

    Page 4-right panel, Line 21: The last 2 sentences were corrected to be consistent with Table 2 as follows: “There was no take among the 18 luminal tumors. However, five of nine TN, and one of the eight HER2+ post-chemotherapy residual tumors took (verified breast tumor).”

  3. 3)

    Page 4-right panel, Table 2: Total implanted for Luminal B should be 14 instead of 18. The total number of implanted 35 was correct.

  4. 4)

    Page 5-left panel, Line 15: HER2+ tumors (7/17 vs. 2/15) should be (7/19 vs. 2/15). P-value is correct.

  5. 5)

    Page 5-left panel, Line 20, The number of luminal tumors should be 18 instead of 22.

The authors sincerely apologize for any inconvenience.

Reference

  1. 1.

    Yu, et al. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study. Breast Cancer Research. 2017;19:130. https://doi.org/10.1186/s13058-017-0920-8.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Liewei Wang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yu, J., Qin, B., Moyer, A.M. et al. Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study. Breast Cancer Res 23, 41 (2021). https://doi.org/10.1186/s13058-021-01420-z

Download citation